Molecular Approaches to Drug Discovery and Development
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (28 February 2025) | Viewed by 10597
Special Issue Editor
Interests: organic synthesis; medicinal chemistry; drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Drug discovery involves many different stages, such as target identification and validation, hit identification, hit-to-lead optimization, and the identification of a candidate for further development. Drug development, on the other hand, includes the optimization of chemical synthesis and drug formulation, preclinical studies, and, eventually, market approval. It is evident that drug development, from the discovery of a promising target to the creation of usable medication, is a costly, long process. It has also become clear that the need for faster drug development requires interdisciplinary cooperation within academia, as well as increased collaboration between industry and academia with a common objective of constantly providing quality medicines.
Organic chemistry has had a major impact on drug discovery by providing simple and efficient, low-cost synthetic pathways, novel methodologies, and reaction mechanisms for the synthesis of new candidate molecules. In addition to drug discovery, organic chemistry is greatly involved in drug development and optimization. The rapid development of biotechnological drugs and synthetic drug delivery systems has re-enforced the role of organic chemistry, as there is a clear need for the development of targeting drugs, nano-drugs, and synthetic drug delivery systems in a controllable, reproducible, and well-defined manner.
This Special Issue will collect the contributions of various types of molecular approaches to drug discovery and development, i.e., the synthesis of potential bioactive molecules and drugs and drug derivatives, including targeted drugs and synthetic novel-type drug delivery systems (DDS). The following categories will form part of this Special Issue: liquid- and solid-phase synthesis methods for the development of bioactive molecules and drugs of any type (small molecules, macromolecules, peptides and their derivatives); methods used to extend drugs’ self-lives (e.g., lipidation, pegylation, chemical/structural modifications, cyclization, etc.); methods used to enhance targeting ability; the development of targeted drug delivery systems; synthetic approaches to the latest oligonucleotide-mediated gene silencing concept. Molecular mechanisms of innovating synthetic approaches/problem solving also form part of this Special Issue. The development of innovative synthetic nano-drugs and vesicular drug delivery systems (DDS) that allow slow release and extend the drugs half-life (e.g., liposomes, nanoparticles, etc.) will also be considered for publication if the applied molecular approaches/chemistries used, either to the DDS or the drug itself, influence the fate of the drug after administration (e.g., synthetic modifications/functionalization, targeted drug-delivery systems, etc.). Initial biological and pharmacological evaluation (including preclinical evaluation) of the suggested compounds/systems is also welcome.
Dr. Spyridon Mourtas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular approaches
- molecular mechanisms
- molecular rearrangements
- liquid- and solid-phase synthesis
- organic molecules
- peptides
- drugs
- chemical modifications
- organic synthesis
- nano-drugs
- synthetic drug delivery systems
- targeting
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
